Association Between Postoperative Administration of L-Arginine and CSA-AKI
Recruiting
Observational Study
Acute Kidney Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 7,000 (estimated)
- Sponsor
- Xijing Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To investigate the association between the the early administration of L-Arginine after CPB-assisted cardiac surgery and the incidence of CS-AKI in adult patients. To test if it can reduce the incidence of post-operative AKI.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adult patients (over 18 years)
* underwent CPB assisted cardiac surgery
* admitted to ICU
Exclusion Criteria:
* congenital heart disease
* underwent deep hypothermic circulatory arrest (DHCA)
* with glomerular filtration rate (eGFR) below 30 mL/min/1.73 m²
Contacts